| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.91B | — | +8.0% |
| Cost of Revenue | $1.36B | — | +8.1% |
| Gross Profit | $551.0M | — | +7.8% |
| R&D Expense | $48.0M | — | +37.1% |
| SG&A Expense | $340.0M | — | +11.1% |
| Operating Income | $102.0M | — | -25.0% |
| Pre-tax Income | $55.0M | — | +266.7% |
| Income Tax | $17.0M | — | +88.9% |
| Net Income | $38.0M | — | +533.3% |
| EPS (Basic) | $0.17 | — | +950.0% |
| EPS (Diluted) | $0.17 | — | +950.0% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $438.0M | -33.7% | -24.1% |
| Accounts Receivable | $1.11B | +3.8% | +6.6% |
| Inventory | $1.36B | +0.2% | +10.5% |
| Current Assets | $3.17B | -5.5% | +3.7% |
| Total Assets | $8.21B | -2.7% | +1.6% |
| Current Liabilities | $1.53B | -12.8% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$145.0M | — | -123.1% |
| Capital Expenditures | $36.0M | — | +16.1% |
| Investing Cash Flow | -$36.0M | — | -16.1% |
| Financing Cash Flow | -$42.0M | — | -90.9% |
| Free Cash Flow | -$181.0M | — | -88.5% |
| -3.0% |
| Long-term Debt | $3.23B | -0.2% | +60.1% |
| Total Liabilities | $5.29B | -4.2% | +11.8% |
| Stockholders' Equity | $2.92B | +0.2% | -12.7% |